Skip to main content

AusPAR: Golimumab (rmc)

Australian Public Assessment Report
Device/Product Name
Simponi
Active ingredients
Golimumab (rmc)
AusPAR Date
Published
Submission Number
PM-2015-01879-1-3
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site